The $11 central target is the arithmetic mean of the verified analyst price targets currently in circulation, calculated from data compiled by S&P Global and cross-checked against brokerage notes. Roughly 11 analysts publish targets on MNTN, spanning a notably wide range of about $6 to $22, with a calculated average of approximately $10.78 (rounded to $11 for readability). This is not an official published consensus, and the dispersion itself is an important signal: bullish and cautious analysts now disagree sharply about the company's trajectory.
The range widened dramatically after MNTN's Q3 2026 results, reported in early November 2026. Evercore ISI described the quarter as a "dramatic Miss & Lower" and downgraded the stock to In Line with a $7 target (down from $22). Citi moved to Neutral from Buy with a $7 target (down from $16), while Loop Capital downgraded to Hold with a $6 target (down from $17). Susquehanna trimmed its target to $12 from $20, Canaccord Genuity cut to $10 from $18, and Freedom Broker reduced to $9 from $16.50, all while retaining positive ratings. On the more bullish end, Needham's Laura Martin maintained an $18 Buy rating, and Tigress Financial held a far higher target in the mid-$20s. This gap between single-digit and low-$20s targets explains why the average sits near $11 while the range remains wide. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
With the stock around $5.19, reaching $11 requires a gain of roughly 112% — a very large move relative to typical analyst expectations. The shares trade near the bottom of a 52-week range of about $4.60 to $14.89, well below the $16 IPO price and reflecting a market capitalization of roughly $390 million against trailing twelve-month revenue of about $324 million (up roughly 18% year over year). The company has transitioned toward profitability and expanding margins, but the most recent quarter's revenue and adjusted EBITDA came in well below Street estimates, resetting expectations lower. A move toward $11 would depend not on a single catalyst but on a sustained re-acceleration of growth and a rebuilding of investor confidence from these depressed levels.
Several verified factors could support a recovery. MNTN operates in the structurally growing CTV advertising market, where performance-based, self-serve buying is taking share from traditional TV. The company has demonstrated meaningful operating leverage: in the first quarter of 2026 it reported double-digit revenue growth, a material beat on adjusted EBITDA, and roughly 770 basis points of margin expansion, aided by AI-driven cost efficiency and agile engineering. The rollout of generative AI tools for ad content creation and recent senior leadership additions are also cited by bullish analysts. A return to faster customer acquisition and revenue growth, combined with continued margin gains, would be the clearest fundamental path back toward the $11 target. From what I see, this operating leverage remains a key differentiator worth monitoring.
The principal obstacle is execution risk following the weak Q3 2026 results. Analysts at Freedom Broker noted that both revenue and adjusted EBITDA fell significantly below their estimates, prompting material cuts to 2026 and 2027 projections. Competition in small-and-mid-sized-business (SMB) performance CTV is intensifying, and Needham has flagged the absence of omni-channel buying options as a competitive limitation amid macroeconomic uncertainty. Broader advertising-sector cyclicality, potential valuation compression in small-cap technology, and the risk of further target cuts if growth does not re-accelerate all weigh against a rapid return to $11. I'm watching this closely after the recent revisions.
The stock's structure reflects a deep drawdown rather than an orderly uptrend. The $4.60 52-week low is the nearest major support zone, while the $5.00 psychological level sits just below the current price. On the upside, the stock would need to reclaim the $6–$7 area where several recently lowered targets cluster, before facing heavier resistance nearer the $10–$12 zone and, ultimately, the $14.89 52-week high and $16 IPO level. Given that the current price is only modestly above its low, any move toward $11 would require a full reversal of the prevailing downtrend structure.
Analyst price targets generally reflect a research horizon of about 12 months, though firms do not always state this explicitly. Investors should watch upcoming quarterly results — the next report is expected around February 2027 — for signs of renewed revenue growth and adjusted EBITDA recovery. Other key items include any further analyst revisions or rating changes, management guidance on customer acquisition, product announcements around generative AI, CTV advertising demand trends, and macroeconomic indicators affecting advertiser spending. None of these should be read as a forecast of whether the $11 level will be reached.
In my own research process, Tickeron's AI Daily Buy/Sell Signals have become a helpful way to track momentum shifts on names like this one. The tool uses artificial intelligence to monitor thousands of stocks and ETFs, delivering Buy, Sell, or Hold signals based on technical behavior and market conditions. It helps surface opportunities and changing trends more efficiently than manual checks alone, which is useful when following a volatile stock through periods of analyst revisions.
The $11 target is the rounded average of current analyst price targets, not a forecast or a guarantee. It sits more than 100% above the latest price near $5.19, making it a very large required move. The bullish case rests on CTV growth, AI-enabled cost discipline, and margin expansion, while the bearish case is anchored in a disappointing Q3 2026 quarter, intensifying SMB competition, and a wave of recent downgrades that left targets scattered from $6 to $22. Whether MNTN can rebuild toward $11 will ultimately depend on whether the company can re-accelerate revenue and regain analyst and investor confidence over the coming quarters.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
It is expected that a price bounce should occur soon.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
Following a +10.20% 3-day Advance, the price is estimated to grow further. Considering data from situations where MNTN advanced for three days, in 61 of 119 cases, the price rose further within the following month. The odds of a continued upward trend are 51%.
MNTN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MNTN as a result. In 21 of 68 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 31%.
The Moving Average Convergence Divergence Histogram (MACD) for MNTN turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 13 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 28%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where MNTN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.
The Aroon Indicator for MNTN entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.193) is normal, around the industry mean (-1.906). P/E Ratio (2.978) is within average values for comparable stocks, (9.554). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.069) among similar stocks. P/S Ratio (2.814) is also within normal values, averaging (70.383).
The Tickeron SMR rating for this company is 47 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. MNTN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MNTN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry PackagedSoftware